Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Latest News
KOC agrees $16bn pipeline deal with Blackstone, Brookfield, KKR
Meliá fully withdraws from Cuba amid economic crisis – report
Man Group PLC : Form 8.3 - AMG Critical Materials N.V
EU approves Saica’s acquisition of Thimm plants in four countries
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.philips.com |
| Audit Risk | 1 |
| Board Risk | 1 |
| Overall Risk | 1 |
| Market Cap | 22.84B |
| Trailing P/E | 23.5 |
| Forward P/E | 13.74 |
| Dividend Rate | 0.85 |
| Dividend Yield | 3.70% |
| Trailing Annual Div. Rate | 0.85 |
| Trailing Annual Div. Yield | 3.67% |
| Trailing EPS | 1 |
| Forward EPS | 1.71 |
| Book Value | 11.97 |
| Price-to-Book | 1.96 |
| Enterprise-to-Revenue | 1.56 |
| Enterprise-to-EBITDA | 13.19 |
| Ex-Dividend Date | 05/12/2026 |
| Earnings Date | 07/28/2026 |
| Earnings Call Date | 07/28/2026 |
| Earnings Average | 0.35 |
| Earnings Low | 0.32 |
| Earnings High | 0.38 |
| Revenue Average | 4.31B |
| Revenue Low | 4.26B |
| Revenue High | 4.36B |